Fine Mark National Bank & Trust Nuvasive Inc Transaction History

Fine Mark National Bank & Trust

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 06, 2020	SELL	$32.82 - $81.13 $114,870 - $283,955	-3,500 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$60.96 - $77.7 $3,230 - $4,118	-53 Reduced 1.49%	3,500 $271,000
Q2 2019 Aug 08, 2019	BUY	$53.69 - $65.47 $190,760 - $232,614	3,553 New	3,553 $208,000
Q4 2018 Feb 07, 2019	SELL	$47.64 - $71.26 $166,740 - $249,410	-3,500 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$52.03 - $71.41 $182,105 - $249,935	3,500 New	3,500 $248,000

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Fine Mark National Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Fine Mark National Bank & Trust with notifications on news.